6/15/2022NMPA Holds Forum to Hear Feedbacks from Pharma MNCs

6/15/2022NHSA Releases the Draft Working Plan and the Application Guide for Adj...

6/14/2022IQVIA: Chinese Retail Pharmacy Sales Down 1.2% in Q1/2022

6/14/2022NHSA Publishes 2021 National Basic Medical Insurance Sector Developmen...

6/14/2022Pharma Giants Turn to Incubators to Tap Chinese Innovation and Hatch S...

6/14/2022FDA's Treatment of China-Developed Drugs Spurs Demands for Multiregion...

6/10/2022Delisting Risk, Souring Relations Are Hurdles for Chinese Biotech Firm...

6/10/2022NHC and SATCM Issue the Rules for Internet Diagnosis and Treatment Reg...

6/9/2022OnCusp and Multitude Enter into an Ex-China Licensing Agreement for a ...

6/7/2022Nicholas Hall Group: Performance of China's Consumer Healthcare Market...

6/7/2022NH's DB6: Top Ten Chinese CHC Brands in 2021

6/7/2022NH's DB6: Chinese OTC Drug Market Forecast 2026/2031

6/7/2022Fosun Pharma Acquires 60% of Singapore OncoCare Medical for $158M

6/7/2022China Issues the Notice on Correction of Irregularities in Drug Procur...

6/7/2022How Shanghai Kept Clinical Trials Going During Lockdown (PharmaDJ)

6/6/2022Pfizer/CStone Cejemly Gets China Approval for Expanded Use in Advanced...

6/6/2022WuXi Biologics Launches First Commercial Drug Product Facility for Pre...

6/6/2022China Issues the 14th Five-Year National Health Plan with A New Focus ...

6/3/2022NeoGenomics's Suzhou Pharma Services Lab Gets CAP Certification

6/3/2022Patient Activeness During Online Medical Consultation in China: Multil...

6/2/2022NMPA Solicits Comments on the Draft Good Manufacturing Practices for D...

6/2/2022China to Initiate Nationwide Unannounced BMI Fund Inspection

6/2/2022Zelixir Biotech Looks to Help Global Monkeypox Drug Development

6/1/2022Xuanzhu and CTTQ-Akeso Tie Up to Develop Penpulimab for Solid Tumors

5/31/2022Recent Executive Moves

5/30/2022SMEI: Review of Chinese Retail Pharmacy Market (Offline and Online)

5/27/2022NMPA Issues Chinese GMP's Clinical Trial Drug Appendix

5/26/2022Henlius and Abbott Enter Semi-Exclusive License Deal for Rituximab and...

5/26/2022Data Snapshot: Top 20 Domestic Class 1 New Drugs by Sales in 2021

5/26/2022April Licensing Trends Show Chinese Biotechs Expanding Beyond Oncology...

Page:80/371 Total number of articles:11111: [First][<<] [78] [79] [80] [81] [82] [>>] [End]